Abstract
A study assessing the potential risks and benefits of antipsychotic dose reduction compared with antipsychotic maintenance has found that dose reduction had no effect on the primary outcome of change in social functioning in patients with recurrent psychosis. However, dose reduction was associated with a greater likelihood of psychotic relapse.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
